Public Health England | September 2019 | Diabetes variation in inpatient activity (VIA) tool
Healthcare professionals can use the variation in inpatient activity (VIA) tool to explore the variation in inpatient activity (bed days in hospital, emergency re-admissions and day case admissions) for patients with diabetes compared to a similar patient population without diabetes. This can help with planning and commissioning local services.
The briefing gives an overview of the tool and presents data from 2014 to 2015 up to 2017 to 2018, showing how inpatient activity for patients with diabetes varies between clinical commissioning groups (CCGs), and how it has changed over time (Source: Public Health England)
Variation in inpatient activity: diabetes tool
Summary of diabetes VIA tool results: 2014 to 2018
Public Health England | April 2019 |Preventing amputations major concern as diabetes numbers rise
Public Health England’s (PHE) analysis of new data from the Diabetes Foot Care Profiles, published by PHE’s National Cardiovascular Intelligence Network, shows that the number of major lower limb amputations (above the ankle) continues to rise – with 7,545 major amputations over the past 3 years between 2015 to 2018, compared with 6,957 between 2012 to 2015.
The overall number of major amputations is increasing, as the number of people with diabetes rises, but the rate among people with diabetes is not significantly increasing.
Key findings from this data show that during the 3-year period of 2015 to 2016 up to 2017 to 2018:
- patients from England had 147,067 hospital stays for diabetic foot disease
- the average length of stay in hospital was 8 days and the total number of days spent in hospital for diabetic foot disease was 1,826,734
- 85,837 individual patients were admitted for foot disease and 33% of these had more than one stay over the 3 years
- the rate of major amputations was greatest among men (male rate 10.5/10,000 population-years compared with females 4.9; and the white population rate of 9.6/10,000 and non-white 2.6)
Full details are at PHE
Public Health England | March 2019 | Barnsley and Rotherham: diabetic eye screening programme
Public Health England (PHE) has now published an Executive summary of quality assurance (QA) visit to Barnsley and Rotherham held on 18 October 2018.
Quality assurance (QA) visits are carried out by the Public Health England screening quality assurance service (SQAS).
Public Health England | March 2019 | Diabetes outcomes versus expenditure (DOVE) in local populations
Public Health England have updated the Diabetes outcomes versus expenditure (DOVE) in local populations.
Healthcare professionals can use the DOVE tool to explore the relationship between spending on diabetes treatment and local clinical outcomes for patients. This can help with planning and commissioning local services.
DOVE tool for CCGs and GP practices
DOVE tool: summary of results 2013 to 2018
Full details available from Public Health England
Diabetes Prevention Week 2019 will run from 1-7 April 2019.
The campaign aims to:
- Raise awareness of the Healthier You: NHS Diabetes Prevention Programme – with the public and healthcare professionals (specifically GPs, Practice Nurses and Pharmacists)
- Raise awareness of the causes of Type 2 diabetes
- Raise awareness of the complications associated with Type 2 diabetes
- Raise awareness of at risk groups – particularly BME populations
Local NHS organisations can order a toolkit from Public Health England which includes everything you need to run your own event, including posters, leaflets and more.
Full detail at Public Health England
Public Health England | February 2019 | Diabetic eye screening: cohort management
This guidance explains the management of the cohort (people on the programme register) for the NHS diabetic eye screening (DES) programme.
This document explains the management of the cohort for diabetic eye screening (DES).
- people who are ineligible or off-register
- situations that require special consideration
- rarer forms of diabetes
(Source: Public Health England)
Diabetic eye screening: cohort management